Abstract
Adaptive online MRI-guided radiotherapy of head and neck cancer requires the reliable segmentation of the parotid glands as important organs at risk in clinically acceptable time frames. This can hardly be achieved by manual contouring. We therefore designed deep learning-based algorithms which automatically perform this task.
Imaging data comprised two datasets: 27 patient MR images (T1-weighted and T2-weighted) and eight healthy volunteer MR images (T2-weighted), together with manually drawn contours by an expert. We used four different convolutional neural network (CNN) designs that each processed the data differently, varying the dimensionality of the input. We assessed the segmentation accuracy calculating the Dice similarity coefficient (DSC), Hausdorff distance (HD) and mean surface distance (MSD) between manual and auto-generated contours. We benchmarked the developed methods by comparing to the inter-observer variability and to atlas-based segmentation. Additionally, we assessed the generalisability, strengths and limitations of deep learning-based compared to atlas-based methods in the independent volunteer test dataset.
With a mean DSC of 0.85± 0.11 and mean MSD of 1.82 ±1.94 mm, a 2D CNN could achieve an accuracy comparable to that of an atlas-based method (DSC: 0.85 ±0.05, MSD: 1.67 ±1.21 mm) and the inter-observer variability (DSC: 0.84 ±0.06, MSD: 1.50 ±0.77 mm) but considerably faster (<1s v.s. 45 min). Adding information (adjacent slices, fully 3D or multi-modality) did not further improve the accuracy. With additional preprocessing steps, the 2D CNN was able to generalise well for the fully independent volunteer dataset (DSC: 0.79 ±0.10, MSD: 1.72 ±0.96 mm)
We demonstrated the enormous potential for the application of CNNs to segment the parotid glands for online MRI-guided radiotherapy. The short computation times render deep learning-based methods suitable for online treatment planning workflows.
Competing Interest Statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust are part of the MR-Linac consortium. After completing this work, Jennifer Kieselmann has become an employee at Varian Medical Systems, Inc. There are no other potential conflicts of interest to declare.
Funding Statement
This work was supported by the Oracle Cancer Trust, as well as the Cancer Research UK Programme (grants C7224/A23275, and C33589/ A19727). The ICR/RMH is part of the Elekta MR-Linac Research consortium. This report is independent research funded by the National Institute for Health Research. CDF would like to acknowledge funding from NIH grants with numbers R25EB025787 and R01DE028290. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data was acquired as part of the LIBRARY (CCR4477) study which was approved by the Royal Marsden Hospital's institutional review board, as well as under research protocols MDACC RCR03-0800, MDACC PA18-0341, and MDACC PA19-0491 which were approved under the auspices of the University of Texas MD Anderson Cancer Center IRB.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the MD Anderson Cancer Center but restrictions apply to the availability of these data, which were used under license for the current study, and so are not yet publicly available.
